D. E. Johnson
#183,730
Most Influential Person Now
D. E. Johnson's AcademicInfluence.com Rankings
D. E. Johnsonbiology Degrees
Biology
#15421
World Rank
#19394
Historical Rank
Cell Biology
#862
World Rank
#882
Historical Rank
Genetics
#1805
World Rank
#1919
Historical Rank
Molecular Biology
#2655
World Rank
#2696
Historical Rank
Download Badge
Biology
D. E. Johnson's Degrees
- PhD Molecular Biology University of California, Berkeley
- Bachelors Biochemistry Stanford University
Why Is D. E. Johnson Influential?
(Suggest an Edit or Addition)D. E. Johnson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Structural and functional diversity in the FGF receptor multigene family. (1993) (1259)
- Signalling by receptor tyrosine kinases. (1993) (1042)
- Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. (2000) (639)
- Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. (1989) (574)
- The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain (1991) (413)
- Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. (1991) (396)
- Implication of cell kinetic changes during the progression of human prostatic cancer. (1995) (391)
- Diverse forms of a receptor for acidic and basic fibroblast growth factors (1990) (345)
- Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities (1992) (327)
- Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. (2000) (258)
- Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. (1994) (252)
- DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies (2014) (208)
- Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. (1998) (198)
- Tumor size: effect on monoclonal antibody uptake in tumor models. (1986) (141)
- Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. (1996) (134)
- DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies (2015) (104)
- Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. (2000) (98)
- p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. (1998) (97)
- Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. (2001) (96)
- Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis. (1997) (96)
- Signal transduction pathways that contribute to myeloid differentiation (2007) (87)
- Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family (2003) (86)
- Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug. (1988) (80)
- Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy. (2000) (77)
- You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia (2014) (74)
- Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. (2000) (71)
- Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. (1986) (67)
- An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern. (1988) (64)
- Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis (2017) (60)
- STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention (2014) (58)
- Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade. (2000) (48)
- Dasatinib promotes ATRA-induced differentiation of AML cells (2010) (45)
- Caspase-mediated degradation of T-cell receptor zeta-chain. (1999) (43)
- Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-XLand XIAP in the prolonged survival of monocytic cells (2003) (42)
- Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice. (2001) (33)
- In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery. (1999) (29)
- Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: no evidence of germ line transduction. (2000) (27)
- Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal. (1998) (27)
- Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium. (1998) (27)
- Athymic mouse model of a human T-cell tumor. (1985) (25)
- The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. (1995) (25)
- Spontaneous renal neoplasms in rats (1993) (24)
- Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates. (1989) (24)
- Secretory protein 7B2 is associated with pancreatic hormones within normal islets and some experimentally induced tumors. (1988) (24)
- DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia. (1986) (21)
- Gefitinib potentiates myeloid cell differentiation by ATRA (2008) (20)
- Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model. (1988) (18)
- Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101. (1988) (18)
- Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein. (1995) (16)
- Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity. (1986) (14)
- Correlates of protective immunity against HIV-1 infection in immunized chimpanzees. (1996) (13)
- Particle--lamella complexes in a case of human benign prostate hyperplasia: brief communication. (1978) (13)
- Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment. (2001) (12)
- Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target (2009) (12)
- Virus-like particles in a case of human prostate carcinoma. (1977) (11)
- Early gene signalling-dependent and -independent induction of apoptosis in Ramos human B cells can be inhibited by over-expression of Bcl-2. (1995) (11)
- Phenylacetic acid halides inhibit estrogen receptor (ER)‐positive MCF‐7 cells, but not ER‐negative human breast cancer cells or normal breast epithelial cells (1996) (11)
- Virologic and immunologic studies of human prostatic carcinoma. (1975) (11)
- Search for oncogenic viruses in human prostate cancer. (1977) (10)
- Establishment of a human B-cell tumor in athymic mice. (1987) (10)
- Activation State-Dependent Substrate Gating in Ca2+/Calmodulin-Dependent Protein Kinase II (2017) (10)
- Recombinant human retinoblastoma protein inhibits cancer cell growth. (1995) (10)
- Bcl-2- and CrmA-inhibitable dephosphorylation and cleavage of retinoblastoma protein during etoposide-induced apoptosis. (1998) (9)
- Analysis of the role of conserved cysteine residues in the bcl-2 oncoprotein. (2000) (8)
- Clear-cell carcinoma in the trachea of a rat. (1991) (7)
- Preclinical trials using an immunoconjugate of T101 and methotrexate in an athymic mouse/human T-cell tumor model. (1988) (5)
- Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. (2001) (4)
- The epidermal growth factor (EGF) receptor gene studied using gene transfer. (1985) (1)
- immunoglobulin domain. receptor forms that differ in their third underlies the mechanisms for generating genes: a common structural arrangement The human fibroblast growth factor receptor (2013) (0)
This paper list is powered by the following services:
